PCLOF
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | 0.00 | $605,652 | $530,317 |
| 2025 Q3 | -0.01 | $889,031 | -$4M |
| 2025 Q2 | -0.01 | $322,769 | $2M |
| 2025 Q1 | -0.01 | $785,022 | -$95,109 |
| 2024 Q4 | -0.01 | $1M | -$391,579 |
| 2024 Q3 | -0.02 | $1M | -$552,473 |
| 2024 Q2 | -0.02 | $783,680 | -$604,988 |
| 2024 Q1 | -0.01 | $240,268 | -$420,340 |